Bristol Myers Squibb announces acquisition of schizophrenia drug manufacturer Karuna for $14 billion
海角七号
发表于 2023-12-23 10:10:40
282
0
0
On December 22nd local time, Bristol Myers Squibb and Karuna Therapeutics announced that they had signed a final merger agreement. According to the agreement, Bristol Myers Squibb has agreed to acquire Karuna for $330.00 per share in cash, with a total share capital value of $14 billion. The board of directors of both companies unanimously approved this acquisition, which is expected to be completed in the first half of 2024. In addition, according to the press release, Karuna's drug for treating adult schizophrenia, KarXT, is expected to be launched in the United States on September 26, 2024.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Nearly 800 drugs in the United States collectively raise prices. Novo Nordisk's "weight loss miracle drug" has risen by 3.5%
- Amazon abandons $1.4 billion acquisition of sweeping robot manufacturer iRobot and plans to lay off 31% of employees
- Lilly plans to launch the obesity drug Telposide in India as early as next year
- Olio manufacturer fined over 2.6 billion yuan for violating EU antitrust laws
- Merck focuses on the development of next-generation cardiac metabolic drugs and competes with oral weight loss therapies
- Aircraft manufacturers using counterfeit titanium components? Boeing and Airbus response: After analysis, the in-service fleet has not been affected
- Johnson&Johnson Long acting Schizophrenic Therapy Approved in China
- Zaiding Medicine: Clinical study of KarXT for the treatment of schizophrenia completed, enrolled patients from mainland China
- Apple's new patent explores the future of Vision Pro headset: relieving pain for people with disabilities and helping them reduce drug dependence
- How is the progress of the world's first new drug for schizophrenia approved in the US and in the Chinese market
-
AIエクスプレスによると、10月3日、米株の人気の中概株盤の前が低くなり、ピッピッピッと5%近く下落し、相多、名創優品、小鵬自動車は3%超下落し、百度、蔚来自動車、京東は2%超下落した。 ...
- SOGO
- 昨天 17:06
- 支持
- 反对
- 回复
- 收藏
-
ナスダック中国の金龍指数は5%超上昇し、楽しい自動車は120%超上昇し、金山雲は18%超上昇し、ピシャリと12%超上昇し、子牛の電動、怪獣の充電は10%超上昇し、愛奇芸は8%超上昇し、テンセント音楽、新東方は7%超上昇 ...
- hecgdge4
- 昨天 10:28
- 支持
- 反对
- 回复
- 收藏
-
10月1日、理想自動車が9月に納入したデータによると、9月に理想自動車が新車53709台を納入し、前年同月比48.9%増となった。 今年第3四半期、理想自動車は前年同期比45.4%増の152831台を納入した。今年9月30日現在、 ...
- 就放荡不羁就h
- 前天 12:06
- 支持
- 反对
- 回复
- 收藏
-
EUが中国の電気自動車に関税を課す方針、独首相と財務相が反発 ドイツ連邦のショルツ首相は現地時間の10月2日、EUが中国の電気自動車に一時的な補助金税を課す紛争を解決するために中国と交渉することを表明した。 ...
- 寒郁轩良
- 7 小时前
- 支持
- 反对
- 回复
- 收藏